Based on the data retrieved from the TogoVar API, there is no mention of rs796053229 being included in pharmacogenomics guidelines such as PharmGKB. The variant is primarily associated with developmental and epileptic encephalopathy and other neurodevelopmental disorders, as indicated by ClinVar data. However, no specific pharmacogenomic information or guidelines are provided for this variant.

If you are looking for pharmacogenomic relevance, it is recommended to consult specialized databases like PharmGKB directly or review literature for any emerging evidence.

---

### English Summary:
1. **Variant Identification**:  
   - **rs number**: rs796053229  
   - **Gene**: SCN8A  
   - **HGVS Notation**: Multiple transcripts, e.g., NM_014191.4:c.5615G>A (p.Arg1872Gln) and NM_014191.4:c.5615G>T (p.Arg1872Leu).  
   - **TogoVar Link**: [TogoVar rs796053229](https://togovar.org/variant/12-51807101-G-A)  

2. **Disease Associations**:  
   - Associated with developmental and epileptic encephalopathy, complex neurodevelopmental disorder, and early infantile epileptic encephalopathy.  

3. **Literature Evidence**:  
   - No specific pharmacogenomic literature is mentioned in the TogoVar data.  

4. **Allele Frequency Comparison**:  
   - Very rare in gnomAD exomes (allele frequency: ~6.84e-07). No population-specific data for Japanese populations is provided.  

5. **GWAS Findings**:  
   - No GWAS findings are mentioned.  

6. **Pharmacogenomics Guidelines**:  
   - Not included in PharmGKB or other pharmacogenomics guidelines based on available data.  

---

### 日本語概要:
1. **バリアント識別**:  
   - **rs番号**: rs796053229  
   - **遺伝子**: SCN8A  
   - **HGVS表記**: 複数のトランスクリプト例: NM_014191.4:c.5615G>A (p.Arg1872Gln) および NM_014191.4:c.5615G>T (p.Arg1872Leu)。  
   - **TogoVarリンク**: [TogoVar rs796053229](https://togovar.org/variant/12-51807101-G-A)  

2. **疾患関連**:  
   - 発達性およびてんかん性脳症、複雑な神経発達障害、乳児期早期てんかん性脳症に関連。  

3. **文献証拠**:  
   - TogoVarデータには薬理ゲノミクスに関する特定の文献は記載されていません。  

4. **アレル頻度比較**:  
   - gnomADエクソームで非常に稀（アレル頻度: 約6.84e-07）。日本人集団に関する特定のデータは提供されていません。  

5. **GWASの発見**:  
   - GWASに関する記載はありません。  

6. **薬理ゲノミクスガイドライン**:  
   - PharmGKBや他の薬理ゲノミクスガイドラインには含まれていないようです。  

---

For further exploration, consult PharmGKB or other pharmacogenomics databases directly.  
詳細な情報を得るには、PharmGKBなどの薬理ゲノミクスデータベースを直接参照してください。